412 related articles for article (PubMed ID: 25883081)
1. Increased late complex device infections are determined by cardiac resynchronization therapy-defibrillator infection.
Unsworth JD; Zaidi A; Hargreaves MR
Europace; 2015 Nov; 17(11):1708-11. PubMed ID: 25883081
[TBL] [Abstract][Full Text] [Related]
2. Lead extraction: The road to successful cardiac resynchronization therapy.
Maciąg A; Syska P; Sterliński M; Przybylski A; Sitkowska E; Oręziak A; Bilińska M; Kuśmierczyk M; Szwed H
Cardiol J; 2015; 22(2):188-93. PubMed ID: 25299498
[TBL] [Abstract][Full Text] [Related]
3. Rate, causes, and impact on patient outcome of implantable device complications requiring surgical revision: large population survey from two centres in Italy.
Palmisano P; Accogli M; Zaccaria M; Luzzi G; Nacci F; Anaclerio M; Favale S
Europace; 2013 Apr; 15(4):531-40. PubMed ID: 23407627
[TBL] [Abstract][Full Text] [Related]
4. Battery drain in daily practice and medium-term projections on longevity of cardioverter-defibrillators: an analysis from a remote monitoring database.
Boriani G; Ritter P; Biffi M; Ziacchi M; Diemberger I; Martignani C; Valzania C; Valsecchi S; Padeletti L; Gadler F
Europace; 2016 Sep; 18(9):1366-73. PubMed ID: 26847076
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes in cardiac resynchronization therapy-defibrillator recipients 80 years of age and older.
Adelstein EC; Liu J; Jain S; Schwartzman D; Althouse AD; Wang NC; Gorcsan J; Saba S
Europace; 2016 Mar; 18(3):420-7. PubMed ID: 26487669
[TBL] [Abstract][Full Text] [Related]
6. PR interval identifies clinical response in patients with non-left bundle branch block: a Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy substudy.
Kutyifa V; Stockburger M; Daubert JP; Holmqvist F; Olshansky B; Schuger C; Klein H; Goldenberg I; Brenyo A; McNitt S; Merkely B; Zareba W; Moss AJ
Circ Arrhythm Electrophysiol; 2014 Aug; 7(4):645-51. PubMed ID: 24963007
[TBL] [Abstract][Full Text] [Related]
7. The clinical course of patients with implantable cardioverter-defibrillators: Extended experience on clinical outcome, device replacements, and device-related complications.
van der Heijden AC; Borleffs CJ; Buiten MS; Thijssen J; van Rees JB; Cannegieter SC; Schalij MJ; van Erven L
Heart Rhythm; 2015 Jun; 12(6):1169-76. PubMed ID: 25749138
[TBL] [Abstract][Full Text] [Related]
8. Battery longevity in cardiac resynchronization therapy implantable cardioverter defibrillators.
Alam MB; Munir MB; Rattan R; Flanigan S; Adelstein E; Jain S; Saba S
Europace; 2014 Feb; 16(2):246-51. PubMed ID: 24099864
[TBL] [Abstract][Full Text] [Related]
9. Applicability of a risk score for prediction of the long-term benefit of the implantable cardioverter defibrillator in patients receiving cardiac resynchronization therapy.
Barra S; Looi KL; Gajendragadkar PR; Khan FZ; Virdee M; Agarwal S
Europace; 2016 Aug; 18(8):1187-93. PubMed ID: 26566940
[TBL] [Abstract][Full Text] [Related]
10. Infections and associated costs following cardiovascular implantable electronic device implantations: a nationwide cohort study.
Clémenty N; Carion PL; Léotoing L; Lamarsalle L; Wilquin-Bequet F; Brown B; Verhees KJP; Fernandes J; Deharo JC
Europace; 2018 Dec; 20(12):1974-1980. PubMed ID: 29672690
[TBL] [Abstract][Full Text] [Related]
11. Complications in recipients of cardioverter-defibrillator or cardiac resynchronization therapy: Insights from Silesian Center Defibrillator registry.
Tajstra M; Gadula-Gacek E; Kurek A; Adamowicz-Czoch E; Olszowski D; Ostręga M; Ciślak A; Pyka Ł; Hawranek M; Lekston A; Poloński L; Gąsior M
Cardiol J; 2017; 24(5):515-522. PubMed ID: 27734455
[TBL] [Abstract][Full Text] [Related]
12. Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker.
Schuchert A; Muto C; Maounis T; Frank R; Boulogne E; Polauck A; Padeletti L;
Europace; 2013 Jan; 15(1):71-6. PubMed ID: 22927665
[TBL] [Abstract][Full Text] [Related]
13. Device-related infection among patients with pacemakers and implantable defibrillators: incidence, risk factors, and consequences.
Nery PB; Fernandes R; Nair GM; Sumner GL; Ribas CS; Menon SM; Wang X; Krahn AD; Morillo CA; Connolly SJ; Healey JS
J Cardiovasc Electrophysiol; 2010 Jul; 21(7):786-90. PubMed ID: 20102431
[TBL] [Abstract][Full Text] [Related]
14. Relation of QRS Duration to Clinical Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients Without Left Bundle Branch Block: The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Substudy.
Biton Y; Kutyifa V; Cygankiewicz I; Goldenberg I; Klein H; McNitt S; Polonsky B; Ruwald AC; Ruwald MH; Moss AJ; Zareba W
Circ Heart Fail; 2016 Feb; 9(2):e002667. PubMed ID: 26823498
[TBL] [Abstract][Full Text] [Related]
15. Facility-Level Variation and Clinical Outcomes in Use of Cardiac Resynchronization Therapy With and Without an Implantable Cardioverter-Defibrillator.
Kramer DB; Normand ST; Volya R; Hatfield LA
Circ Cardiovasc Qual Outcomes; 2018 Dec; 11(12):e004763. PubMed ID: 30562069
[TBL] [Abstract][Full Text] [Related]
16. Incidence and Costs Related to Lead Damage Occurring Within the First Year After a Cardiac Implantable Electronic Device Replacement Procedure.
Nichols CI; Vose JG; Mittal S
J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26873688
[TBL] [Abstract][Full Text] [Related]
17. The wearable cardioverter defibrillator as a bridge to reimplantation in patients with ICD or CRT-D-related infections.
Castro L; Pecha S; Linder M; Vogler J; Gosau N; Meyer C; Willems S; Reichenspurner H; Hakmi S
J Cardiothorac Surg; 2017 Nov; 12(1):99. PubMed ID: 29178898
[TBL] [Abstract][Full Text] [Related]
18. Effect of cardiac resynchronization therapy and implantable cardioverter defibrillator on quality of life in patients with heart failure: a meta-analysis.
Chen S; Yin Y; Krucoff MW
Europace; 2012 Nov; 14(11):1602-7. PubMed ID: 23104857
[TBL] [Abstract][Full Text] [Related]
19. Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon.
Boriani G; Braunschweig F; Deharo JC; Leyva F; Lubinski A; Lazzaro C
Europace; 2013 Oct; 15(10):1453-62. PubMed ID: 23696624
[TBL] [Abstract][Full Text] [Related]
20. Infective endocarditis and risk of death after cardiac implantable electronic device implantation: a nationwide cohort study.
Özcan C; Raunsø J; Lamberts M; Køber L; Lindhardt TB; Bruun NE; Laursen ML; Torp-Pedersen C; Gislason GH; Hansen ML
Europace; 2017 Jun; 19(6):1007-1014. PubMed ID: 28073883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
